JAK2V617F mRNA metabolism in myeloproliferative neoplasm cell lines

被引：0
|
作者：
P Nauroy
F Delhommeau
F Baklouti
机构：
[1] mRNA Metabolism in Normal and Pathological Cells,
[2] CNRS UMR 5534,undefined
[3] Université Lyon 1,undefined
[4] Sorbonne Universités,undefined
[5] UPMC Univ Paris 06,undefined
[6] GRC no. 07,undefined
[7] Groupe de Recherche Clinique sur les Myéloproliférations Aiguës et Chroniques MyPAC,undefined
[8] AP-HP,undefined
[9] Hôpital Saint-Antoine,undefined
[10] Laboratoire d'Hématologie,undefined
[11] Sorbonne Universités,undefined
[12] UPMC Univ Paris 06,undefined
[13] UMR_S 938,undefined
[14] CDR Saint-Antoine,undefined
[15] INSERM,undefined
[16] UMR_S 938,undefined
[17] CDR Saint-Antoine,undefined
[18] Current address: Institut de Génomique Fonctionnelle de Lyon,undefined
[19] Ecole Normale Supérieure,undefined
[20] Lyon,undefined
[21] France,undefined
来源：
Blood Cancer Journal | 2014年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：e222 / e222
相关论文
共 50 条
  • [21] A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients
    Na Xu
    Li Ding
    Changxin Yin
    Xuan Zhou
    Lin Li
    Yulin Li
    Qisi Lu
    Xiao-li Liu
    Annals of Hematology, 2015, 94 : 865 - 867
  • [22] The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
    Orbell, Lai Yee
    Abutheraa, Nouf
    Duncombe, Andrew S.
    Mcmullin, Mary Frances
    Mesa, Ruben
    Mcshane, Charlene M.
    James, Glen
    Anderson, Lesley A.
    EJHAEM, 2023, 4 (04): : 1071 - 1080
  • [23] JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
    Nielsen, Camilla
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Kofoed, Klaus F.
    Birgens, Henrik S.
    HAEMATOLOGICA, 2014, 99 (09) : 1448 - 1455
  • [24] JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
    Lee, Sandy
    Wong, Helen
    Castiglione, Melissa
    Murphy, Malea
    Kaushansky, Kenneth
    Zhan, Huichun
    STEM CELLS, 2022, 40 (04) : 359 - 370
  • [25] JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm
    Lee, Sandy
    Wong, Helen
    Castiglione, Melissa
    Murphy, Malea
    Kaushansky, Kenneth
    Zhan, Huichun
    BLOOD, 2021, 138
  • [26] A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients
    Xu, Na
    Ding, Li
    Yin, Changxin
    Zhou, Xuan
    Li, Lin
    Li, Yulin
    Lu, Qisi
    Liu, Xiao-li
    ANNALS OF HEMATOLOGY, 2015, 94 (05) : 865 - 867
  • [27] JAK2V617F influences epigenomic changes in myeloproliferative neoplasms
    Chen, Chih-Cheng
    Chiu, Chia-Chen
    Lee, Kuan-Der
    Hsu, Chia-Chen
    Chen, Hong-Chi
    Huang, Tim H. -M.
    Hsiao, Shu-Huei
    Leu, Yu-Wei
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 494 (3-4) : 470 - 476
  • [28] EPIGENETIC CHANGES IN JAK2V617F POSITIVE MYELOPROLIFERATIVE DISORDERS
    Uras, A.
    Fancello, M. A.
    Monne, M.
    Piras, G.
    Palmas, A. D.
    Gaviano, E.
    Noli, A.
    Bianchi, A.
    Gabbas, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 356 - 356
  • [29] JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Salem H. Alshemmari
    Reshmi Rajaan
    Reem Ameen
    Mohammad A. Al-Drees
    Marwa R. Almosailleakh
    Annals of Hematology, 2014, 93 : 791 - 796
  • [30] Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders
    Marchetti, Marina
    Falanga, Anna
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (3-4) : 148 - 159
12345